Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and Brain Vascular Disorders

levonorgestrel has been researched along with Brain Vascular Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chhabra, A; Patel, A; Shaltoni, H; Sun, RL1
Meade, TW1
Sivin, I1
Green, L; Wysowski, DK1
Adami, HO; Bergström, R; Falkeborn, M; Lithell, H; Persson, I; Terént, A1
Koepsell, TD; Longstreth, WT; Petitti, DB; Psaty, BM; Quesenberry, CP; Raghunathan, TE; Schwartz, SM; Sidney, S; Siscovick, DS1
Chang, CL; Farley, TM; Marmot, MG; Meirik, O; Poulter, NR1

Other Studies

7 other study(ies) available for levonorgestrel and Brain Vascular Disorders

ArticleYear
Reversible cerebral vasoconstriction syndrome after levonorgestrel-releasing intrauterine device placement-Case report.
    Headache, 2023, Volume: 63, Issue:5

    Topics: Cerebrovascular Disorders; Constriction, Pathologic; Female; Headache; Headache Disorders, Primary; Humans; Levonorgestrel; Middle Aged; Seizures; Vasoconstriction; Vasospasm, Intracranial

2023
Effects of progestogens on the cardiovascular system.
    American journal of obstetrics and gynecology, 1982, Mar-15, Volume: 142, Issue:6 Pt 2

    Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins

1982
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Obstetrics and gynecology, 1995, Volume: 86, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Cerebrovascular Disorders; Drug Implants; Female; Humans; Incidence; Levonorgestrel; Pseudotumor Cerebri; Risk Factors; United States; United States Food and Drug Administration

1995
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Obstetrics and gynecology, 1995, Volume: 85, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Cerebrovascular Disorders; Combined Modality Therapy; Debridement; Drainage; Drug Implants; Female; Hospitalization; Humans; Levonorgestrel; Plasmapheresis; Pseudotumor Cerebri; Purpura, Thrombotic Thrombocytopenic; Surgical Wound Infection; United States; United States Food and Drug Administration

1995
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
    Archives of internal medicine, 1993, May-24, Volume: 153, Issue:10

    Topics: Cerebrovascular Disorders; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Menopause; Middle Aged; Multivariate Analysis; Risk Factors; Sweden; Time Factors

1993
Norplant implants and cardiovascular disease.
    Contraception, 1998, Volume: 57, Issue:5

    Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Myocardial Infarction

1998
Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet (London, England), 1999, Jul-24, Volume: 354, Issue:9175

    Topics: Adult; Case-Control Studies; Cerebrovascular Disorders; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors

1999